SureTrader
Home > Boards > US Listed > Biotechs > Neurotrope Inc. (NTRP)

Sitting on 7.02 average sometimes I'm wrong but

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Whoopddew Member Profile
 
Followed By 0
Posts 38
Boards Moderated 0
Alias Born 01/14/18
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2018 5:59:12 PM
Neurotrope to Present at BIO CEO & Investor Conference PR Newswire (US) - 2/7/2018 8:30:00 AM
Neurotrope to Present at NobleCon 14th Annual Institutional Investor Conference PR Newswire (US) - 1/25/2018 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/8/2018 9:01:48 AM
Neurotrope's Bryostatin Improves Cognition in Patients with Advanced Alzheimer's Disease Based on Further Analysis of Phase 2... PR Newswire (US) - 1/5/2018 9:28:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 12/22/2017 5:04:48 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 12/22/2017 5:03:02 PM
Neurotrope to Present Additional Findings from Bryostatin Phase 2 Trial in Advanced Alzheimer's Disease PR Newswire (US) - 12/19/2017 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/18/2017 5:35:56 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/18/2017 5:32:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/18/2017 5:29:21 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/18/2017 5:25:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/18/2017 5:22:45 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/18/2017 4:07:22 PM
Neurotrope Appoints Charles S. Ryan as Chief Executive Officer PR Newswire (US) - 12/18/2017 8:30:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 12/4/2017 4:11:29 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/3/2017 5:18:44 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 10/31/2017 6:06:01 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 10/30/2017 5:06:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/19/2017 4:07:57 PM
Neurotrope Provides Business Update and Reports Second Quarter 2017 Financial Results PR Newswire (US) - 8/9/2017 8:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/8/2017 5:19:08 PM
Neurotrope Presents Phase 2 Data Assessing Bryostatin-1 in Moderate-to-Severe Alzheimer's Patients at AAIC 2017 PR Newswire (US) - 7/19/2017 11:36:00 AM
Neurotrope Presents Phase 2 Data Assessing Bryostatin-1 in Moderate-to-Severe Alzheimer's Patients at AAIC 2017 PR Newswire (US) - 7/19/2017 11:16:00 AM
Neurotrope to Present Bryostatin Phase 2 Data in an Oral Presentation at AAIC 2017 Meeting PR Newswire (US) - 6/29/2017 9:30:00 AM
Whoopddew   Friday, 02/09/18 05:36:06 PM
Re: runncoach post# 5730
Post # of 5809 
Sitting on 7.02 average sometimes I'm wrong but I feel really good on this one

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist